All current and archived content of Pathogens and Global Health will be available to view and download until May 26th thanks to a promotion ran by our publisher, Maney Publishing. Please sign up at their website in order to take advantage of this offer.
“World Malaria Day” was established and approved at the 60th World Health Assembly (WHA) in March 2007. It replaced “Africa Malaria Day” which was commemorated every year since 2001 on 25 April. The purpose of the day is to raise awareness of malaria as a disease that is preventable and treatable and to mobilize communities across the world to get involved in the fight against it.
To help raise awareness of the disease Pathogens and Global Health has made many malaria-related content freely available. Please visit the papers below.
- Revealing the secrets of malaria parasite interaction with blood group A sugars
- Infertility resulting from transgenic I-PpoI male Anopheles gambiae in large cage trials
For more information about World Malaria Day, please visit the official website
Issue 2 of the 2013 volume of Pathogens and Global Health is online. The issue contains a focus on infectious diseases that affect the poor urban setting of the world, including a report on the factors that cause disease in urban street children in Peru, and the factors causing intestinal parasitosis, anaemia and malnutrition in children in Ethopia.
The issue includes one Open Access commentary article:
- Revealing the secrets of malaria parasite interaction with blood group A sugars
The rest of the issue is available here
SUBMISSION PROCEDURE
Articles must be submitted online at http://pgh.edmgr.com.
Instructions on how to register and submit a paper are available at this URL and author tutorials can be found at http://www.maneypublishing.com/web/editorial_manager_tutorials/.
For an initial submission you must upload a Word file containing the complete paper or a Word file containing the text, references, tables and figure captions plus an individual file of each figure, prepared to the specification laid out below. You will be asked to input separately the title,
abstract (if applicable) and keywords for the article and contact details for all authors.
When submitting a revised article you must upload:
(i) a text file in Word or rtf format, containing the revised text, references, tables and figure captions, prepared to the specification outlined below;
(ii) a separate high-resolution image file of each figure (see guidelines below);
(iii) a response to the referees’ comments, as a Word or PDF file. It is not necessary to upload, for a second time, files that were uploaded with the initial submission and have not been altered.
OPEN ACCESS OPTION FOR AUTHORS
Authors or their funding agency, may sponsor an article for open access publication. For information on article charges and instructions on how to exercise this option click here.
BRIEF FORMATTING AND STYLE GUIDELINES
In preparing the manuscript as a Word or rtf file, there is no need to format the article to a specific layout or template, but please include italic or bold type where necessary. Manuscripts must be written in English. Authors not fully familiar with English may find it helpful to obtain advice from a fluent English speaker before submitting their article. Double spacing should be used throughout all portions of your manuscript and all pages should be numbered consecutively. Consistency in spacing, punctuation, and spelling is essential.
Submissions are vetted for quality of English and may be rejected on these grounds before being sent for review. Authors may wish to use a language-editing service to refine the use of English in their manuscript before submission. For information about language-editing services and discounts for Maney authors, please visit http://www.maneypublishing.com/languageediting.
Use of an editing service does not guarantee that your paper will be accepted for publication. A decision will be made following the usual peer review process.
In general, abbreviations should not be used without explanation the first time they occur and SI units should be used wherever possible. However, use of ‘ml’ is permitted and x2, DNA, ELISA, HPLC, IFAT, Ig, P, PCR,N, RAPD, RFLP, RNA, S.D., S.E. and v. (for versus) do not need expansion. The solidus (egg/g) is preferred to the superscript (eggs g-1).
Papers should be set out as follows, with each section beginning on a separate sheet: title page, abstract (if applicable) and key words, text, acknowledgements, references, tables, captions to illustrations.
Abstracts The abstract should consist of not more than 250 words summarising the contents of the article. Abstracts are not required for Short Communications.
References should be presented in the Vancouver style, numbered in the order in which they are first cited and listed in numerical order on a separate page in single spacing at the end of the paper. Arabic numerals in superscript form are used outside the punctuation mark, e.g.6
Journal articles should be abbreviated as they appear in the MEDLINE Journals Database.
Engers HD, Godal T. Malaria vaccine development: current status. Parasitol Today. 1998:14:56–64.
Books
Madsen H, Appleton CC, Chimbari M (editors). Medical and veterinary malacology in Africa. Charlottenlund: DBL Publications; 2001.
Internet Documents
Organisation, title, date and URL, e.g. WHO Climate Change Adaptation to Protect Human Health, 2010. Available from http://www.who.int/globalchange/projects/adaptation/en/index.html
ILLUSTRATIONS
Illustrations should be numbered sequentially using Arabic numerals for figures. These should be submitted on separate pages. Each must have a legend. Sub-figures should be appropriately lettered in lower-case letters (e.g. a, b); the size of letters should be appropriate to that of the illustration. Within the text, figures and tables should be referred to by number (e.g. Figure 1; Table 1).
Special attention should be paid to the clarity of any line drawings or graphs, and $, #, &, %, + and – are the preferred symbols on line graphs. Units involving multiplication (e.g. eggs/g faeces ×10-3) should be avoided, either by converting the units (eggs/mg faeces) or by renumbering the relevant axis.
The author will be required to provide images in CMYK format, as TIFF or JPEG files, at the high resolution needed for printing. Images should be submitted at a minimum input scanning resolution of 300 dpi for full colour, 350–400 dpi for half tones, 600 dpi for slides or transparencies, 800 dpi for simple line and 1200 dpi for fine line illustrations. Please note that the final reproduction quality is dependent on the quality of the original illustration. Where graphs are included that were originally in colour, ensure that the components (e.g. blocks or segments) are suitably contrasting, by shading or texture, in black and white.
The author will be required to obtain written evidence of permission to reproduce images (in all formats, in perpetuity and in all geographical regions worldwide) from the copyright owner and will be liable for any fee charged by the owner of the image. The legend should include relevant credit of the permission of the copyright holder to reproduce the image.
Adjustments of brightness, contrast or colour balance may be applied to the entire image provided the result does not mislead the viewer.
ONLINE COLOUR
Colour illustrations will be published in the online version of the journal free of charge. Images submitted in colour will be published in black and white in the printed journal. A few colour figures are printed in each issue free of charge. If, however, the publisher’s allowance for free colour is exceeded, authors may be asked to bear the costs of colour printing if they want their images to be printed in colour. Production colour costs can be
obtained from the Editor.
PUBLISHING ETHICS
Maney’s healthcare journals are now members of COPE (the Committee on Publication Ethics). Pathogens and Global Health supports the ethical principles set out by the Committee on Publication Ethics (COPE) available here on their website.
Protection of Human Subjects and Animals in Research
Clinical Research and papers reporting experiments on healthy volunteers, patients or animals must conform to the guidelines approved by a named Research Ethical Committee (Institutional or National) and conform with the Helsinki Declaration of 1975, as revised in 2000. A statement to this effect should be included at submission stage. Authors should be aware that if their study required ethical approval but ethical approval was not obtained, then the paper will be rejected.
Informed Consent
Patients have a right to privacy and wherever possible informed consent must be obtained before identifying information is published. During the online submission process, authors are asked to indicate if they have included identifying patient information in their article, in the form of photographs, personal information or specific details of treatment.
For those who have included identifying information, they must indicate if they were able to obtain permission to use this personal information (written or verbal). In some cases, the editors may require identifying information to be removed or photographs to be adapted.
Conflict-of-Interest Notification
It is the policy of Maney Publishing and Pathogens and Global Health to adhere to the Conflict-of-Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org/ethical_4conflicts.html.
Relationships that could be viewed as presenting a conflict of interest must be declared at the submission stage. The corresponding author, or author responsible for the submission, must make the declaration on behalf of all co-authors. If there are no conflicts of interest, authors should explicitly state that there are none during the submission process.
Any affiliation with an organisation with a financial interest, direct or indirect, in the subject matter of the paper should be explicitly stated. Authors should make a full disclosure. Authors should also identify individuals who provided writing or other assistance and disclose the funding source for the assistance.
The statement of conflict of interest will be printed at the end of the paper if accepted for publication after peer review. All papers in Pathogens and Global Health either include a statement of conflict of interest, or indicate explicitly that there is none.
COPYRIGHT
Authors who wish to reproduce sections of text, tables or images from previously published sources or where the copyright is owned by a third party must obtain written permission from the copyright holder (usually the publisher) and the author(s)/artist(s) of the original material. A line giving the full source of the material should be included in the manuscript, including any specific wording stipulated by the copyright holder. Copyright is required for use in all formats (including digital, and (where appropriate) colour), in perpetuity and in all geographical regions worldwide. The author will be liable for any fee charged by the owner of the image. For more information and advice please see www.maneypublishing.com/authors/copyright.
PERMISSIONS
Any reproduction from this journal apart from for the purposes of review, private research or “fair dealing”, must have the permission of the copyright holder. Requests for such permission must be addressed to permissions@maneypublishing.com, who act on behalf of the copyright holder. In all cases, acknowledgement of the journal must be made.
PROOFS
Proofs will be supplied by email in PDF format to the first-named or nominated author. Proofs are supplied for checking and making essential typographical corrections only, not for general revision, alteration, or changes to illustrations. Revised proofs will not be supplied to authors.
E-PRINTS
Authors receive a screen-resolution PDF file (e-print) of the published version of their paper that they may circulate to colleagues, but may not use for commercial purposes or place into an institutional or subject specific repository. Pre- and post-print versions of an article may be posted in repositories, subject to full acknowledgement of the journal.
Visit the Copyright and Permissions page www.maneypublishing.com/authors/copyright for full details, including exceptions to this policy. More information is also provided in the Assignment of Copyright Form distributed to authors with their proofs.
COMMERCIAL REPRINTS
Reprints of articles published in the Journal can be purchased through the Publisher. Please contact the Managing Editor for information and quotes: l.mcivor@maneypublishing.com
Issue 1 of Pathogens and Global Health is available online. The first issue from this year’s volume features a range of topics, including malaria, TB and meningitis. Here is a selection:
The full issue is available here
Issue 7 of Pathogens and Global Health is now available online. The issue focuses on novel research and breakthroughs in the area of insect vectors for bacteria and disease. The issue includes the following Open Access papers, available free, as well as others:
The full issue is available here
Issue 5 of Pathogens and Global Health is now available online. The special issue centres around the topic of Neurocysticercosis, with bulletins on diagnosis, prevalance, management, treatment and control of the disease.
The issue provides a special report on the status of Taeniasis/Cysticercosis. The issue features several publications within specific geographic contexts as well as reviews that consider issues of diagnosis, treatment and management. Our guest editors, Dr Oscar del Brutto and Prof Hector Hugo Garcia consider hopes for its elimination and eradication.
For an overview of the issue, please read Dr Oscar del Brutto & Prof Hector Hugo Garcia’s editorial here.
Taenia solium cysticercosis: new challenges for an old scourge
Dr Oscar del Brutto & Prof Hector Hugo Garcia
The taeniasis/cysticercosis disease complex is a public health challenge for most of the developing world, and is increasingly recognized in developed countries due to mass immigration, refugee movements, international travelling and overseas business affairs. This parasitic disease is caused by the pork tapeworm Taenia solium which normally inhabits—in its adult form—in the small intestine of man, producing vague intestinal complaints or no symptoms at all; humans become Taenia carriers after being infected by eating undercooked pork containing cysticerci, the larval stage of the parasite. While pigs are the natural hosts for the larval stage of this tapeworm (intermediate host), humans may also become infected with the cystic larvae, thus developing cysticercosis. Recent evidence favors the concept that human cysticercosis is a disease mainly transmitted from person-to-person, i.e., a healthy individual ingesting T. solium eggs directly from a Taenia carrier by the fecal-oral route or through non-hygienic handling of food. As per most zoonosis, taeniasis/cysticercosis is closely linked to poverty and disproportionately affects underserved populations.
While taeniasis and cysticercosis have long been known and clinically well described, advances in the diagnosis and treatment of neurocysticercosis during the past few decades have increased the knowledge on this disease and improved the prognosis of most affected patients. Development of modern neuroimaging in the late 1970s, the introduction of specific antiparasitic drugs soon after, and improved serological diagnosis and monitoring are rapidly changing our views on the disease. Epidemiological evidence has demonstrated much larger endemic regions along the world, including most of Africa and vast parts of China, as well as clear trends of the introduction of imported cases in non-endemic countries. However, much remains to be learned and some controversial aspects in the taeniasis/cysticercosis complex remain open to discussion.
This issue of Pathogens & Global Health is devoted to basic and clinical aspects of T. solium cysticercosis. The increased epidemic burden of neurocysticercosis in the US, the high prevalence of the disease in South Africa, recent advances in immunological diagnosis of neurocysticercosis, as well as clinical manifestations of the disease, the relationship between neurocysticercosis and epileptogenesis, recent advances in therapy, and control measures directed to eradicate Taenia solium taeniasis/cysticercosis, are discussed by experts in the subject, all of them researchers with extensive hands-on experience on this parasitic disease.
Taeniasis/cysticercosis continues to be a serious public health problem in most of the world. Much has been gained in understanding the disease, as well as on its diagnosis and management, and more recently, some hopes of elimination and perhaps eradication have arisen. In this context, this issue will be a welcome addition to the bookshelves of physicians working on this parasitic disease and a reference volume for updated information.
The editorial was originally published here